<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="878">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05149729</url>
  </required_header>
  <id_info>
    <org_study_id>E.16313</org_study_id>
    <nct_id>NCT05149729</nct_id>
  </id_info>
  <brief_title>Mid-Term Natural Course Postoperative of Crowe Type III-IV Hip Dysplasia</brief_title>
  <official_title>Mid-Term Natural Course of Lower Extremity and Spine After Total Hip Arthroplasty in Patients With Crowe Type III-IV Hip Dysplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of preoperative and postoperative mid-term course of patients with Crowe Type 3&#xD;
      and Type 4 hip dysplasia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Crowe type 3 and type 4 patients who underwent shortened hip replacement surgery will be&#xD;
      followed up for 2 years.&#xD;
&#xD;
      Patients will be called for routine outpatient controls at the 2nd week, 6th week, 3rd month,&#xD;
      6th month, 12th month, 24th month.&#xD;
&#xD;
      Patients will be referred to the physical therapy specialist for abduction strengthening and&#xD;
      pelvis tilt corrective exercises starting from the 6th week.&#xD;
&#xD;
      Scoliosis and orthoroentgenography x-rays will be taken at the last control of the patients.&#xD;
&#xD;
      HHS, WOMAC hip score and SF-12 score will be obtained from the patients. Scores, lower&#xD;
      extremity and spine angles will be evaluated after the last examinations performed at 12 and&#xD;
      24 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Anticipated">June 10, 2024</completion_date>
  <primary_completion_date type="Anticipated">May 10, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients over the age of 18 who underwent Crowe Type 3 and Type 4 shortened hip prosthesis</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>The degree of improvement in Vomac score will be evaluated by looking at preoperative and postoperative 12th month Vomac scores.( 0-12th month )</time_frame>
    <description>The WOMAC score range, which indicates the clinical satisfaction of the patients, is between 0-100.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hip Arthropathy</condition>
  <condition>Hip Dysplasia</condition>
  <arm_group>
    <arm_group_label>Crowe type 3 and 4 patients undergoing shortened hip replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinical and radiological results of Crowe type 3 and 4 patients who underwent shortened hip prosthesis at 12 and 24 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Shortened hip arthroplasty</intervention_name>
    <description>Crowe type 3 and 4 patients who underwent shortened hip prosthesis</description>
    <arm_group_label>Crowe type 3 and 4 patients undergoing shortened hip replacement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Crowe type 3 and 4 patients over 18 years of age who had shortened hip replacement&#xD;
             surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Crowe type 1 or 2 patients over 18 years of age who had shortened hip replacement&#xD;
             surgery&#xD;
&#xD;
          -  Patients who have previously operated on the contralateral hip&#xD;
&#xD;
          -  Patients who underwent shortened hip replacement for a reason other than developmental&#xD;
             dysplasia of the hip&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gökçer Uzer</last_name>
    <role>Study Director</role>
    <affiliation>Bezmialem Vakif University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hakan batuhan kaya</last_name>
    <phone>00905542294339</phone>
    <email>hbatuhan-kaya-123@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bezmialem Vakıf University</name>
      <address>
        <city>İstanbul</city>
        <state>Fatih</state>
        <zip>34500</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hakan Batuhan Kaya</last_name>
      <phone>00905542294339</phone>
      <email>hbatuhan-kaya-123@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Hakan Batuhan Kaya</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Murat Sarıkaş</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>https://DOI.ORG/10.1016/J.ARTH.2019.04.028</url>
    <description>EFFECTS OF TOTAL HIP ARTHROPLASTY ON AXIAL ALIGNMENT</description>
  </link>
  <link>
    <url>https://DOI.ORG/10.1016/J.ARTH.2017.05.044</url>
    <description>CHANGES IN HIP, KNEE, AND ANKLE CORONAL ALIGNMENTS AFTER TOTAL HIP ARTHROPLASTY WITH TRANSVERSE FEMORAL SHORTENING OSTEOTOMY FOR UNILATERAL CROWE TYPE IV DEVELOPMENTAL DYSPLASIA OF THE HIP</description>
  </link>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>December 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2021</study_first_posted>
  <last_update_submitted>December 3, 2021</last_update_submitted>
  <last_update_submitted_qc>December 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Murat Sarikas</investigator_full_name>
    <investigator_title>Orthopaedic surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Hip Dislocation</mesh_term>
    <mesh_term>Developmental Dysplasia of the Hip</mesh_term>
    <mesh_term>Hip Dislocation, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

